Drug discovery takes years to complete. Testing a single compound can cost more than £1.5 billion. Experiments on animals often fail to predict human behaviours and responses, because traditional animal anatomy often does not accurately mimic the human body. For these reasons, there is a vast need for other ways to emulate human diseases in vitro in order to accelerate the research and development of new drugs. Anindya Mookerjea, founder of S-Cube Technologies, explains why, to get the best of drug research using organ-on-a-chip (OOC) methods, connecting it to an IoT sensor would be the most effective.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2020/02/Best-Practices-of-IoT-Implementation.pdf” width=”100%” height=”900px” style=”border:0;”]